Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis
暂无分享,去创建一个
S. Karlik | D. Lee | J. Noseworthy | M. Vandervoort | C. Wong | G. Ebers | S. Wiebe | S J Karlik | M K Vandervoort | J H Noseworthy | G C Ebers | D H Lee | G P Rice | S Wiebe | M Hopkins | C J Wong | L Hewitt | M. Hopkins | L. Hewitt | G. Rice
[1] D. Paty,et al. Magnetic Resonance Imaging in the Assessment of Disease Activity in Multiple Sclerosis , 1988, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[2] N. Patronas,et al. Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history , 1991, Annals of neurology.
[3] B E Kendall,et al. Magnetic resonance imaging of the optic nerve in optic neuritis , 1988, Neurology.
[4] G. Paulson,et al. Magnetic resonance imaging and clinical correlations in multiple sclerosis , 1988, Journal of the Neurological Sciences.
[5] A J Petkau,et al. Systemic lymphoblastoid interferon therapy in chronic progressive multiple Sclerosis. I. Clinical and MRI evaluation , 1990, Neurology.
[6] W. I. McDonald,et al. Heterogeneity of blood‐brain barrier changes in multiple sclerosis , 1990, Neurology.
[7] W. Mcdonald,et al. Lessons from magnetic resonance imaging in multiple sclerosis , 1989, Trends in Neurosciences.
[8] J. Gilbert,et al. Unsuspected multiple sclerosis. , 1983, Archives of neurology.
[9] A. Thompson,et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.
[10] R. Rudick,et al. Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials. , 1989, Archives of neurology.
[11] A. A. Eisen,et al. MRI in the diagnosis of MS , 1988, Neurology.
[12] D. Li,et al. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients , 1989, Annals of neurology.
[13] B. Bass,et al. Mulocal CT enhancement in MS , 1984, Neurology.
[14] L. Ketonen,et al. A follow-up study of very low field MRI findings and clinical course in multiple sclerosis , 1988, Journal of the Neurological Sciences.
[15] G Johnson,et al. Precise relaxation time measurements of normal‐appearing white matter in inflammatory central nervous system disease , 1989, Magnetic resonance in medicine.
[16] J. G. Phadke,et al. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. , 1983, Journal of neurology, neurosurgery, and psychiatry.
[17] P. Hänny,et al. [Visually evoked responses as follow-up parameters in multiple sclerosis]. , 1989, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis.
[18] J. Becker. Letter: Garlic pyelography. , 1973, Lancet.
[19] D. Li,et al. Benign versus chronic progressive multiple sclerosis: Magnetic resonance imaging features , 1989, Annals of neurology.
[20] A. Thompson,et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. , 1990, BMJ.
[21] D. Paty. Multiple Sclerosis: Assessment of Disease Progression and Effects of Treatment , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[22] B E Kendall,et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.
[23] D. MacManus,et al. PATHOGENESIS OF PROGRESSIVE MULTIPLE SCLEROSIS , 1989, The Lancet.
[24] Michael P. Jones,et al. Magnetic resonance imaging in clinically‐definite multiple sclerosis , 1990, The Medical journal of Australia.
[25] D. Pelz,et al. Optic neuritis and orbital lesions: lipid-suppressed chemical shift MR imaging. , 1991, Radiology.
[26] H I Goldberg,et al. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. , 1988, Radiology.
[27] D. MacManus,et al. EARLY LESION OF MULTIPLE SCLEROSIS , 1988, The Lancet.
[28] U. Stendahl,et al. Haptoglobin groups in ovarian carcinoma. , 1988, Human heredity.
[29] D. Paty,et al. Magnetic resonance imaging and laboratory aids in the diagnosis of multiple sclerosis , 1991, Annals of neurology.
[30] A. Thompson,et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[31] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[32] S. Atlas,et al. Multiple sclerosis disease activity correlates with gadolinium‐enhanced magnetic resonance imaging , 1987, Annals of neurology.
[33] D. Li,et al. Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six months , 1989, Annals of neurology.
[34] J. Oger,et al. Multiple sclerosis , 1988, Neurology.
[35] D. Li,et al. The lesion of multiple sclerosis , 1989, Neurology.
[36] S W Atlas,et al. Multiple sclerosis: gadolinium enhancement in MR imaging. , 1986, Radiology.